Vir Biotechnology Appoints Jeff Calcagno M.D. as Executive Vice President and Chief Business Officer
SAN FRANCISCO, May 15, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer. D… [read more]






